A Randomized, Double-blind, Multicenter, Phase II Study to Assess the Safety, Tolerability, and Efficacy of ZD6474 in Combination With Docetaxel (TAXOTEREâ„¢) in Subjects With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) After Failure of Prior Platinum-based Chemotherapy.
Vandetanib, Docetaxel
Non-Small Cell Lung Cancer
Phase 2
Datasets and document are available as per Sanofi Policy and criteria
May 2017